Publications dans lesquelles il/elle collabore avec Natalia Carrillo López (18)

2024

  1. Novel Biomarkers of Bone Metabolism

    Nutrients, Vol. 16, Núm. 5

  2. RANKL, but Not R-Spondins, Is Involved in Vascular Smooth Muscle Cell Calcification through LGR4 Interaction

    International Journal of Molecular Sciences, Vol. 25, Núm. 11

  3. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Effects of a Losartan-Antioxidant Hybrid (GGN1231) on Vascular and Cardiac Health in an Experimental Model of Chronic Renal Failure

    Nutrients, Vol. 15, Núm. 8

  2. Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  3. MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 7, pp. 1729-1740

  4. Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2589-2597

  5. Phosphorus May Induce Phenotypic Transdifferentiation of Vascular Smooth Muscle Cells through the Reduction of microRNA-145

    Nutrients, Vol. 15, Núm. 13

  6. Redox Metabolism and Vascular Calcification in Chronic Kidney Disease

    Biomolecules, Vol. 13, Núm. 9

  7. Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes

    International journal of molecular sciences, Vol. 24, Núm. 6

  8. Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment

    Nutrients, Vol. 15, Núm. 6

2021

  1. Chronic Kidney Disease—Mineral and Bone Disorders: Pathogenesis and Management

    Calcified Tissue International, Vol. 108, Núm. 4, pp. 410-422

  2. Effects of calcitriol and paricalcitol on renal fibrosis in CKD

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 36, Núm. 5, pp. 793-803

  3. Fibrosis in chronic kidney disease: Pathogenesis and consequences

    International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-19

  4. The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 36, Núm. 4, pp. 618-631

2019

  1. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease

    Nephrology Dialysis Transplantation, Vol. 34, Núm. 6, pp. 934-941

2016

  1. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease

    Kidney International, Vol. 90, Núm. 1, pp. 77-89

  2. Lamin A is involved in the development of vascular calcification induced by chronic kidney failure and phosphorus load

    Bone, Vol. 84, pp. 160-168